|
|
| | LEI-105
(LEI105) Basic information |
| Product Name: | LEI-105
(LEI105) | | Synonyms: | LEI-105
(LEI105);LEI105;6-Phenyl-1-(6-(p-tolyl)oxazolo[4,5-b]pyridin-2-yl)hexan-1- one;1-Hexanone, 1-[6-(4-methylphenyl)oxazolo[4,5-b]pyridin-2-yl]-6-phenyl- | | CAS: | 1800327-36-9 | | MF: | C25H24N2O2 | | MW: | 384.47 | | EINECS: | | | Product Categories: | | | Mol File: | 1800327-36-9.mol |  |
| | LEI-105
(LEI105) Chemical Properties |
| Boiling point | 568.4±52.0 °C(Predicted) | | density | 1.155±0.06 g/cm3(Predicted) | | pka | -2.12±0.50(Predicted) |
| | LEI-105
(LEI105) Usage And Synthesis |
| Description | LEI105 is a potent, highly selective, and reversible dual DAGL-α/DAGL-β inhibitor. Diacylglycerol lipase (DAGL)-α and -β are enzymes responsible for the biosynthesis of the endocannabinoid 2-arachidonoylglycerol (2-AG). |
| | LEI-105
(LEI105) Preparation Products And Raw materials |
|